INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Systematic review / meta-analysis / 2024

Higher serum vitamin B12 concentrations were linked to an increased risk of all-cause mortality, especially in older adults.

A systematic review and dose-response meta-analysis of 22 cohort studies (92,346 individuals, 10,704 all-cause deaths) evaluated serum vitamin B12 levels and mortality risk. Each 100 pmol/L increase in serum vitamin B12 was associated with a 4% higher risk of all-cause mortality in the general population (adjusted HR 1.04, 95% CI 1.01 to 1.08) and a 6% higher risk in older adults (adjusted HR 1.06, 95% CI 1.01 to 1.13). High concentrations (>600 pmol/L) were linked to all-cause mortality (adjusted HR 1.50, 95% CI 1.29 to 1.74) and CVD mortality (adjusted HR 2.04, 95% CI 0.99 to 4.19), but not cancer mortality (adjusted HR 1.56, 95% CI 0.82 to 2.95). Evidence was mixed for cardiovascular mortality and limited for cancer mortality.

Shows an association, not proof of cause and effect.

Study type
Systematic review and dose-response meta-analysis
Who was studied
92,346 individuals across 22 cohort studies (10,704 all-cause deaths)
What was measured
All-cause, cardiovascular, and cancer mortality

THE PAPER

The origin of vitamin B12 levels and risk of all-cause, cardiovascular and cancer specific mortality: A systematic review and dose-response meta-analysis.

Liu K, Yang Z, Lu X, Zheng B, Wu S, Kang J, Sun S, Zhao J. Arch Gerontol Geriatr, 2024.

PubMed 38252787 ↗DOI 10.1016/j.archger.2023.105230 ↗

Heart & arteriesCancerNutrients & adequacyHealthy aging & longevity

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.